Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.
Clinical Trials Arena on MSN13h
BMS’ Phase II trial of CAR T cell therapy meets primary endpointBristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
In a breakthrough for influenza research, scientists have discovered immune cells that can recognise influenza (flu) viruses even as they mutate, raising hopes for a longer-lasting vaccine and a ...
In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...
Business Insider on MSN1d
T-Mobile's Starlink beta test will target 'dead zones' — and Verizon and AT&T customers can sign up tooT-Mobile Starlink will offer connectivity in areas not covered by cell towers. Registration for the free beta is open to ...
T-Mobile said 500,000 square miles of the U.S., which is unreachable by terrestrial cell towers, can now stay connected.
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves the ability of immune cells to combat cancer for ...
T-Mobile Starlink service will offer free direct-to-cell satellite coverage for all registrations until July, even to customers from rival carriers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback